EUVIMEDEUVIMED entdecken
Crossref

CD71 + erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response

K Czubak, T M Grzywa, K Sidor-Dzitkowska, Z Pilch, K Bielak, G Hoser, O Gewartowska, M Malecka-Gieldowska, J Barankiewicz, F Garbicz, O Ciepiela iD, P Juszczynski und 5 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.19914 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von K Czubak und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Multiple Myeloma, Antigens, CD, Erythroid Cells, Receptors, Transferrin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Science Centre in Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM), one of the most frequent haematological malignancies, significantly increases the risk of bacterial infections due to treatment‐related side effects, comorbidities and cancer‐induced immune deficiencies. Recently, CD71 + erythroid cells (CECs) have been identified as key immunomodulators in neonates and cancer patients, but their role in MM progression remains unclear. Using a murine MM model, closely resembling human disease, we observed that MM progression is associated with anaemia and an increase in immature CECs, which are characterized by elevated arginase 2 (ARG2) expression. These MM‐associated CECs suppress T‐cell proliferation, contributing to impaired immune responses. Notably, ARG2 deficiency in mice led to slower MM progression and improved survival. Furthermore, MM‐bearing mice exhibited higher susceptibility to Listeria monocytogenes infections, mirroring the increased infection risk in MM patients. Our findings suggest that ARG2‐expressing CECs play a critical role in MM‐associated immune suppression and infection susceptibility, pointing out ARG2 as a potential therapeutic target to enhance immune function and reduce infection risks in MM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAntigens, CDErythroid CellsReceptors, TransferrinListeriosisAnimalsMiceListeria monocytogenesHumansArginaseDisease ProgressionDisease Models, AnimalMice, KnockoutMice, Inbred C57BL

Stichwörter der Autor:innen

erythropoiesisimmunologyinfectionmultiple myelomamurine model

Substanzen

Antigens, CDCD71 antigenReceptors, TransferrinArginase

Autor:innen und Institutionen

  • Laboratory of Experimental Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • International Institute of Molecular and Cell Biology, Warsaw, Poland.
  • Department of Laboratory Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

ORCID-Profile: O Ciepiela, D Nowis

Förderung

  • National Science Centre in Poland

Zitieren

APA

Czubak, K., Grzywa, T. M., Sidor-Dzitkowska, K., Pilch, Z., Bielak, K., Hoser, G., Gewartowska, O., Malecka-Gieldowska, M., Barankiewicz, J., Garbicz, F., Ciepiela, O., Juszczynski, P., Owczarek, A., Wegrzynowicz, M., Skirecki, T., Golab, J., & Nowis, D. (2025). CD71 + erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response. British Journal of Haematology. https://doi.org/10.1111/bjh.19914

Vancouver

Czubak K, Grzywa TM, Sidor-Dzitkowska K, Pilch Z, Bielak K, Hoser G, et al. CD71 + erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response. British Journal of Haematology. 2025. doi:10.1111/bjh.19914

BibTeX
@article{Czubak2025,
  author = {Czubak, K and Grzywa, T M and Sidor-Dzitkowska, K and Pilch, Z and Bielak, K and Hoser, G and Gewartowska, O and Malecka-Gieldowska, M and Barankiewicz, J and Garbicz, F and Ciepiela, O and Juszczynski, P and Owczarek, A and Wegrzynowicz, M and Skirecki, T and Golab, J and Nowis, D},
  title = {CD71 + erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.19914}
}
Kostenlos starten →